Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary hemorrhagic telangiectasia.

David S Williams1

  • 1Ohio National Financial Services, One Financial Way, Cincinnati, OH 45242, USA.

Journal of Insurance Medicine (New York, N.Y.)
|November 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation of tumor-infiltrating gamma-delta T cells in human colorectal cancer with MHC-I loss.

Clinical & translational immunology·2026
Same author

Hypocomplementaemic urticarial vasculitis with mesangioproliferative glomerulonephritis, interstitial nephritis and absent immune staining.

Internal medicine journal·2026
Same author

Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers.

BMJ oncology·2025
Same author

Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.

Clinical & experimental metastasis·2025
Same author

The photoreceptor outer segment: Development and renewal.

Current topics in developmental biology·2025
Same author

Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.

Communications biology·2025

Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder causing fragile blood vessels. These abnormal vessels in the skin, mucosa, and organs lead to frequent and potentially severe bleeding episodes.

Area of Science:

  • Vascular Medicine
  • Genetics
  • Hereditary Disorders

Background:

  • Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder affecting blood vessel formation.
  • Characterized by the development of arteriovenous malformations (AVMs) in various organs.
  • These AVMs are prone to rupture, leading to significant bleeding.

Purpose of the Study:

  • To describe the clinical and genetic characteristics of hereditary hemorrhagic telangiectasia.
  • To highlight the diagnostic challenges and management strategies for HHT.
  • To emphasize the impact of HHT on patient quality of life.

Main Methods:

  • Review of existing literature on HHT.
  • Analysis of patient case studies.
  • Genetic testing and diagnostic criteria assessment.

Related Experiment Videos

Main Results:

  • HHT presents with diverse clinical manifestations, including nosebleeds, gastrointestinal bleeding, and neurological complications.
  • Genetic mutations in genes like ENG, ACVRL1, and SMAD4 are associated with HHT.
  • Early diagnosis and multidisciplinary management are crucial for improving outcomes.

Conclusions:

  • HHT is a complex inherited vascular disorder requiring comprehensive care.
  • Further research is needed to develop targeted therapies for HHT.
  • Increased awareness and understanding of HHT are essential for affected individuals and healthcare providers.